Product Introduction
An Everolimus Eluting Stent is a drug-eluting coronary stent designed to release everolimus, an antiproliferative agent that helps prevent restenosis by inhibiting excessive tissue growth inside the artery. It is used during percutaneous coronary intervention to restore blood flow in narrowed or blocked coronary arteries. The stent integrates a metallic scaffold with a biocompatible polymer coating for controlled drug delivery.
Product History
Everolimus eluting stents were developed as an advancement over earlier drug-eluting stents to improve safety and efficacy. Everolimus offered better control over cell proliferation and improved healing response. Innovations in polymer technology and stent structure enhanced flexibility, deliverability, and long-term outcomes. Today, these stents are widely used due to their proven clinical performance.
Short Description
Everolimus Eluting Stents are advanced cardiovascular devices designed for effective treatment of coronary artery disease. Advin Health Care provides high-quality stents engineered for optimal drug release and vessel support. These stents significantly reduce the risk of restenosis after angioplasty. Advin Health Care ensures reliability, innovation, and precision in every product. They are trusted by cardiologists across the globe.
Surgeries Related to Product
- Percutaneous Coronary Intervention (PCI)
- Coronary Angioplasty
- Treatment of Coronary Artery Disease
- Complex Cardiac Procedures
- Emergency Cardiac Interventions
Instructions for Use
- Load the stent onto the delivery system
- Advance through the guiding catheter to the target lesion
- Position accurately within the artery
- Inflate the balloon to deploy the stent
- Confirm proper expansion and blood flow
Clinical Benefits
- Minimizes restenosis risk
- Promotes faster endothelial healing
- Provides controlled drug release
- Improves long-term procedural success
Product Also Knows As
everolimus DES, drug eluting coronary stent, antiproliferative stent, medicated stent, coronary DES
Market Demand and Global Trends
The global demand for everolimus eluting stents is increasing due to rising cardiovascular disease cases and advancements in interventional cardiology. Healthcare providers prefer these stents for their safety profile and improved clinical outcomes. Continuous research and innovation are enhancing stent technology. Expanding access to cardiac care is further boosting market growth.
Advin Everolimus Eluting Stent Description
Advin Health Care is a globally leading manufacturer of Everolimus Eluting Stents, offering advanced, high-quality solutions for effective coronary interventions and superior patient outcomes.
Get Connected:
+91 75037 27248 | cardiology@advinhealthcare.com | www.advincardiology.com
